Sanacorp Pharmaholding AG Sustainability Profile
Sanacorp Pharmaholding AG, commonly referred to as Sanacorp, is a prominent player in the pharmaceutical distribution industry, headquartered in Germany. Established in 1970, the company has grown to become a key provider of pharmaceutical products and services across Europe, with a strong operational presence in Germany and other major European markets. Specialising in the wholesale distribution of pharmaceuticals, Sanacorp offers a diverse range of products, including prescription medications, over-the-counter drugs, and healthcare solutions. What sets Sanacorp apart is its commitment to quality and efficiency, ensuring that healthcare providers receive timely access to essential medicines. With a solid market position, Sanacorp has achieved notable milestones, reinforcing its reputation as a trusted partner in the healthcare sector.
DitchCarbon Score
How does Sanacorp Pharmaholding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanacorp Pharmaholding AG's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanacorp Pharmaholding AG's reported carbon emissions
Sanacorp Pharmaholding AG, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Sanacorp may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action, often setting science-based targets to align with global climate goals. However, without specific emissions data or commitments from Sanacorp, it is challenging to assess their position within this evolving landscape.
How Carbon Intensive is Sanacorp Pharmaholding AG's Industry?
How Carbon Intensive is Sanacorp Pharmaholding AG's Location?
Sanacorp Pharmaholding AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sanacorp Pharmaholding AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
